IJCS | Volume 32, Nº2, March/April 2019

151 impedance analysis in patients with acute decompensated heart failure. Circ J. 2015;79(12):2616–22. 24. Garlet AB, CardosoDM, Santos TD, Pereira SN, Albuquerque IM. Relação entre classe funcional e fração de ejeção do ventrículo esquerdo em pacientes com doença coronariana candidatos. Sci Med (Porto Alegre). 2017;27(3):292–6. 25. Riley JP, Masters J. Practical multidisciplinary approaches to heart failure management for improved patient outcome. Eur Heart J Suppl. 2016;18(Suppl G):G43–52. 26. Gandhi S, MoslehW, Sharma UC, Demers C, FarkouhME, Schwalm JD. Multidisciplinary heart failure clinics are associated with lower heart hospitalization andmortality: systematic review andmeta-analysis. Can J Cardiol. 2017;33(10):1237–44. 27. Santos JJA , Plewka JEA, Brofman PRS. Qualidade de vida e indicadores clínicos na insuficiência cardíaca: análise multivariada. Arq Bras Cardiol.2009;93(2):149-56. 28. Nomoto H, Satoh Y, Kamiyama M, Yabe K, Masumura M, Sakakibara A, et al. Mechanisms of diuresis for acute decompensated heart failure by Tolvaptan. Int Heart J. 2017;58(4):593–600. 29. Farias G, Thieme RD, Teixeira LM, Heyde ME, Bettini S, Radominski R. Body composition changes assessed by bioelectrical impedance and their associations with functional class deterioration in stable heart failure patients. Nutr Hosp. 2016;33(3):623–8. 30. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Papacosta O, Sattar N. The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin. Int J Cardiol. 2014;171(1):49–55. 31. Scrutinio D, Passantino A, Guida P, Ammirati E, Oliva F, Sarzi Braga S, et al. Relationship among body mass index, NT-proBNP, and mortality in decompensated chronic heart failure. Heart Lung J Acute Crit Care. 2017;46(3):172–7. 32. CescauA, VanAelst LNL, BaudetM, Cohen Solal A, Logeart D. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction. ESC Heart Fail. 2017;4(4):686-9. 33. QinW, Liu F, Wan C. AU-shaped association of bodymass index and all- cause mortality in heart failure patients: A dose-response meta-analysis of prospective cohort studies. Cardiovasc Ther. 2017;35(2):e12232 34. Springer J, Springer J-I, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017;4(4):492–8. 35. Karst FP, Vieira RM, Barbiero S. Relação da espessura domúsculo adutor do polegar e avaliação subjetiva global em unidade de terapia intensiva cardiológica. Rev Bras Ter Intensiva. 2015;27(4):369–75. 36. Carbone S, Lavie CJ, Arena R. Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc. 2017;92(2):266–79. 37. Gastelurrutia P, Lupón J, de AntonioM, Zamora E, DomingoM, Urrutia A, et al. Body mass index, body fat, and nutritional status of patients with heart failure: The PLICA study. Clin Nutr. 2015;34(6):1233–8. 38. Alves FD, Souza GC, Clausell N, Biolo A. Prognostic role of phase angle in hospitalized patients with acute decompensated heart failure. Clin Nutr. 2016;35(6):1530–4. 39. Nunez J, Mascarell B, Stubbe H, Ventura S, Bonanad C, Bodi V, et al. Bioelectrical impedance vector analysis and clinical outcomes in patients with acute heart failure. J Cardiovasc Med. 2016;17(4):283–90. Rocha et al. Nutritional assessment in heart failure Int J Cardiovasc Sci. 2019;32(2)143-151 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License